Nebenwirkungen · Sifrol
SIFROL 0.088 mg tablets SIFROL 0.18 mg tablets SIFROL 0.35 mg tablets SIFROL 0.7 mg tablets · Abschnitt 4.8 · PDF-Seite 10–11
HOS-086628 · Präparat HOS-083320
10 disorders Vascular hypotension disorders Respiratory, dyspnoea thoracic, and hiccups mediastinal disorders Gastrointestinal nausea constipation disorders vomiting Skin and hypersensitivity subcutaneous pruritus tissue disorders rash Reproductive spontaneous system and penile breast disorders erection General fatigue peripheral oedema dopamine disorders and agonist administration withdrawal site conditions syndrome including apathy, anxiety, depression, fatigue, sweating and pain Investigations weight decrease including decreased appetite weight increase 1 This side effect has been observed in post-marketing experience. With 95% certainty, the frequency category is not greater than uncommon, but might be lower. A precise frequency estimation is not possible as the side effect did not occur in a clinical trial database of 1 395 patients with Restless Legs Syndrome treated with pramipexole.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-06-30T12:07:00Z · SHA-256 b4f30a08cef428369f4933c2b378c5c4863a47cff3160855eb93c9a7a44d185f · Passage ea3e0940fa1275b893537ec4482a2038dddbb56682768e76f62bf269915ba7c2 · Zeichen 9006–11610 im Abschnitt